Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-23-004422
Filing Date
2023-07-10
Accepted
2023-07-10 06:06:07
Documents
3
Period of Report
2023-07-07

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_070723.htm 6-K 28743
2 GRAPHIC logo.jpg GRAPHIC 5115
3 GRAPHIC logo2.jpg GRAPHIC 11402
  Complete submission text file 0001171843-23-004422.txt   52704
Mailing Address LICHTSTRASSE 35 BASEL V8 CH 4056
Business Address LICHTSTRASSE 35 BASEL V8 CH 4056 01141613241111
NOVARTIS AG (Filer) CIK: 0001114448 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-15024 | Film No.: 231078152
SIC: 2834 Pharmaceutical Preparations